FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of June 2008
Commission File Number: 001-33911
RENESOLA LTD
No. 8 Baoqun Road, YaoZhuang
Jiashan, Zhejiang 314117
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82- N/A
RENESOLA LTD
Form 6-K
Page | ||
3 | ||
4 |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
RENESOLA LTD | ||
By: |
/s/ Xianshou Li | |
Name: |
Xianshou Li | |
Title: |
Chief Executive Officer |
Date: June 24, 2008
3
RENESOLA LTD
CLOSING OF FOLLOW-ON PUBLIC OFFERING
ReneSola Ltd (ReneSola or the Company), a leading global manufacturer of solar wafers, is pleased to announce the closing of its follow-on public offering of American Depositary Shares (ADSs) (the Offering).
Details of the Offering
A total of 10,350,000 ADSs, each representing two shares of the Company, were sold in the Offering at a price of US$20.50 per ADS.
Of the ADSs sold in the Offering (excluding the over-allotment option), 8,577,220 ADSs were new shares issued by ReneSola and 422,780 ADSs were sold by certain selling shareholders (the Selling Shareholders), including certain directors of the Company. The underwriters exercised their over-allotment option to purchase a further 972,720 additional ADSs from ReneSola and an aggregate of 377,280 additional ADSs from the Selling Shareholders.
The net proceeds of the Offering, including exercise of the over-allotment option, received by the Company were approximately US$187.0 million, after deducting underwriting discounts and commissions but before offering expenses.
The Companys ADSs are traded on the New York Stock Exchange under the ticker symbol SOL. The ticker symbol of the Companys shares on the AIM market of the London Stock Exchange (AIM) is SOLA.
Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc. acted as joint book runners and Piper Jaffray & Co., Lazard Capital Markets LLC and Oppenheimer & Co. Inc. acted as co-managers for the Offering.
ReneSolas registration statement relating to the ADSs sold in the Offering has been declared effective by the United States Securities and Exchange Commission. This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The Offering was made only by means of a prospectus forming a part of the effective registration statement. A copy of the prospectus relating to the offering may be obtained by contacting Credit Suisse Securities (USA) LLC, Eleven Madison Avenue, New York, New York 10010-3629, or by telephone at 1-800-221-1037; or by contacting Deutsche Bank Securities Inc., Attn: Prospectus Department, 100 Plaza One, Floor 2, Jersey City, NJ 07311-3901, by telephone at 1-800-503-4611, or by e-mail at prospectusrequest@list.db.com.
Separate from the Offering, the Company has issued 40,000 shares to Panjian Li, Chief Strategy Officer of ReneSola, following his exercise of options. The shares resulting from the exercise have been converted into ADSs and sold in the Offering.
4
Application for admission to AIM has been made for the 19,139,880 new shares represented by the ADSs being sold by the Company and the new ADSs being sold by Panjian Li. Admission of the new shares is expected to take place on 24 June 2008.
Following the closing of the Offering, there are 137,624,912 shares in issue.
Details of the Selling Shareholders
800,060 ADSs, representing 1,600,120 shares were sold by the Selling Shareholders, including the exercise of the over-allotment option by the underwriters.
Details of the effect of shares sold in the Offering are set out below. Ownership interests are calculated based on each persons proportionate interest in the Company.
Shares Beneficially Owned Prior To The Offering |
Shares Sold in the Offering |
Shares Beneficially Owned After The Offering |
% Held Following the Offering | |||||
Xianshou Li |
23,863,437 | 597,208 | 23,266,229 | 16.9 | ||||
Yuncai Wu |
10,476,505 | 262,310 | 10,214,195 | 7.4 | ||||
Zhengmin Lian |
13,387,732 | 334,118 | 13,053,614 | 9.5 | ||||
Xiangjun Dong |
10,477,355 | 261,484 | 10,215,871 | 7.4 | ||||
Charles Xiaoshu Bai |
273,333 | 75,000 | 198,333 | 0.14 | ||||
Panjian Li |
60,000 | 60,000 | | | ||||
Binghua Huang |
20,000 | 10,000 | 10,000 | 0.01 |
(1) | The shares held beneficially and sold in the Offering and through the exercise of the over-allotment option are held through Ruixin Holdings Limited, a company owned and controlled by Xianshou Li. |
(2) | The shares held beneficially and sold in the Offering and through the exercise of the over-allotment option are held through Yuncai Holdings Limited, a company which is owned and controlled by Yuncai Wu. |
(3) | The shares held beneficially and expected to be sold in the Offering and through the exercise of the over-allotment option are held through Ruixin Holdings Limited and Yuncai Holdings Limited. |
(4) | Panjian Li exercised options over a total of 40,000 shares, all of which were sold in the Offering and through the exercise of the over-allotment option. |
Lock-up Agreements
Each of the Selling Shareholders and the remaining directors and executive officers of the Company has agreed, subject to certain exceptions, not to transfer or dispose of, directly or indirectly, any shares in the Company, in the form of ADSs or otherwise, or any securities convertible into or exchangeable or exercisable for shares in the Company, in the form of ADSs or otherwise, for a period of 90 days from the date of the final prospectus. After the 90 day period, the shares which are subject to the lock-up agreements may be sold subject to the restrictions under Rule 144 of the US Securities Act of 1933 or by means of a registered public offering.
Enquiries:
In China:
Charles Bai, CFO
ReneSola Ltd
Tel: +86 573 8477 3061
Email: charles.bai@renesola.com
Mr. Derek Mitchell
Ogilvy Public Relations Worldwide (Beijing)
Tel: +86 (10) 8520-6284
E-mail: derek.mitchell@ogilvy.com
In the United States:
Mr. Jeremy Bridgman
Ogilvy Public Relations Worldwide (New York)
Tel: +1 (212) 880-5363
E-mail: jeremy.bridgman@ogilvypr.com
In the UK:
Tim Feather/Richard Baty
Hanson Westhouse Limited
Tel: +44 20 7601 6100
Email: tim.feather@hansonwesthouse.com
About ReneSola
ReneSola Ltd (ReneSola) (AIM: SOLA, NYSE: SOL) is a leading global manufacturer of solar wafers, which are thin sheets of crystalline silicon material primarily used in the production of solar cells. ReneSola has accumulated extensive experience and expertise in developing and using monocrystalline wafer production technologies, has expanded operations into multicrystalline wafer production and has moved upstream into virgin polysilicon manufacturing. ReneSola maintains dedicated raw material procurement personnel in China, the United States and Singapore and possesses a global network of suppliers and customers that include some of the leading global manufacturers of solar cells and modules. For more information about ReneSola, please visit www.renesola.com.